NIH-Funded Research Identifies HDDC2 as Key Driver in Liver Cancer Progression, Influencing Patient Survival and Treatment Strategies
Rapid Read

NIH-Funded Research Identifies HDDC2 as Key Driver in Liver Cancer Progression, Influencing Patient Survival and Treatment Strategies

What's Happening? Research conducted under the auspices of the National Institutes of Health (NIH) has identified HDDC2 as a significant factor in the progression of hepatocellular carcinoma (HCC), the most common type of liver cancer. The study, which utilized data from The Cancer Genome Atlas (TCG
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.